{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029295","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.918168+00:00","generated_at":"2026-05-31T15:54:15.985399+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Protagenic Therapeutics receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period","bullets":["Nasdaq notified PTIX on July 24, 2024 of non-compliance with minimum $1.00 bid price for 30 consecutive business days.","Company has until January 20, 2025 to regain compliance; requires closing bid of $1.00 for at least 10 consecutive days.","If not compliant by Jan 20, 2025, PTIX may qualify for an additional 180-day cure period if it meets other listing standards.","Failure to cure could lead to delisting; the company may appeal any delisting determination to a Nasdaq hearings panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029295","json":"https://secwatch.observer/filing/0001493152-24-029295.json","markdown":"https://secwatch.observer/filing/0001493152-24-029295.md","text":"https://secwatch.observer/filing/0001493152-24-029295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/0001493152-24-029295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:54:15.985399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}